Gonzalez-Fierro, A <br/><br/>
Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Aug 2011 
 - 519-24 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/cp201526  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Antihypertensive Agents--administration & dosage<br/>Case-Control Studies<br/>DNA Methylation--drug effects<br/>Delayed-Action Preparations<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Hydralazine--administration & dosage<br/>Male<br/>Neoplasms--drug therapy<br/>Phenotype<br/>Tablets<br/>Young Adult